Pharmaceutical

Coroner Warns of Fatal Flaws in Penicillin Allergy Checks
Clinical & Pharma Coroner Warns of Fatal Flaws in Penicillin Allergy Checks

In a deeply troubling incident that has reverberated through the medical field, Margaret McNaughton tragically passed away on December 13, 2024, at New Cross Hospital in Wolverhampton, UK, after suffering a fatal allergic reaction to a penicillin-based antibiotic. Despite her documented allergy to

How Will Trump's Tariffs Impact Ireland's Pharma Industry?
Clinical & Pharma How Will Trump's Tariffs Impact Ireland's Pharma Industry?

President Donald Trump's recent announcement of potential tariffs on imported pharmaceuticals has sent shockwaves through global markets, with Ireland, a powerhouse in the pharmaceutical sector, standing at the forefront of concern. As a key supplier to the U.S. market, Ireland faces the daunting

Takeda Pharmaceutical Stock: Mixed Signals and Outlook
Clinical & Pharma Takeda Pharmaceutical Stock: Mixed Signals and Outlook

In the ever-shifting landscape of the pharmaceutical industry, Takeda Pharmaceutical Co ADR (TAK) stands as a notable contender, drawing significant attention from investors navigating the complexities of the stock market. With a market capitalization of $44.28 billion and a workforce of over

Can Trump Force Big Pharma to Slash US Drug Prices?
Clinical & Pharma Can Trump Force Big Pharma to Slash US Drug Prices?

Imagine a scenario where the cost of life-saving medications in the United States drops dramatically overnight, easing the financial burden on millions of families who struggle to afford essential drugs. This vision is at the heart of a recent bold move by President Donald Trump, who has directly

Why Is Teva Pharma Stock Rising After Q2 2025 Results?
Clinical & Pharma Why Is Teva Pharma Stock Rising After Q2 2025 Results?

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has captured the attention of investors with a notable uptick in its stock price following the release of its second-quarter financial results, which showed a mix of challenges and successes. On Wednesday, the stock surged by 2.36% to $16.94, a

Why Are ADHD Prescriptions Soaring in England?
Clinical & Pharma Why Are ADHD Prescriptions Soaring in England?

In England, the landscape of ADHD diagnoses and prescriptions has markedly shifted, reflecting growing awareness and changing societal attitudes toward the condition. Over the decade, ADHD diagnoses have surged as individuals and healthcare systems increasingly recognize the symptoms of this

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later